Docusign (NASDAQ:DOCU) Now Covered by UBS Group

Equities research analysts at UBS Group began coverage on shares of Docusign (NASDAQ:DOCU – Get Free Report) in a report released on Thursday, Benzinga reports. The brokerage set a “neutral” rating and a $85.00 price target on the stock. UBS Group‘s price target suggests a potential upside of 12.98% from the stock’s current price.

Several other equities research analysts also recently issued reports on the company. Evercore set a $65.00 target price on Docusign in a research report on Friday, September 4th. Robert W. Baird upped their price target on Docusign from $55.00 to $72.00 and gave the company a “neutral” rating in a research report on Friday, September 4th. BTIG Research upped their price objective on shares of Docusign from $75.00 to $90.00 and gave the stock a “buy” rating in a report on Wednesday. Bank of America lifted their price objective on Docusign from $58.00 to $64.00 and gave the stock an “underperform” rating in a report on Friday, September 4th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a report on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $69.50.

Read Our Latest Stock Analysis on Docusign

Docusign Stock Down 1.8%

NASDAQ:DOCU traded down $1.34 during trading hours on Thursday, reaching $75.23. The company had a trading volume of 1,030,201 shares, compared to its average volume of 3,797,247. The firm has a market cap of $14.06 billion, a price-to-earnings ratio of 45.98, a P/E/G ratio of 2.79 and a beta of 0.80. Docusign has a twelve month low of $40.16 and a twelve month high of $85.90. The business’s 50-day simple moving average is $74.70 and its two-hundred day simple moving average is $56.14.

Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. The business had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. Docusign had a return on equity of 18.29% and a net margin of 9.82%. The company’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.30 EPS. As a group, equities analysts predict that Docusign will post 2.15 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider James P. Shaughnessy sold 12,000 shares of the firm’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $68.80, for a total value of $825,600.00. Following the transaction, the insider directly owned 50,591 shares of the company’s stock, valued at approximately $3,480,660.80. This trade represents a 19.17% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 14,676 shares of the stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $69.41, for a total transaction of $1,018,661.16. Following the completion of the sale, the insider owned 75,928 shares of the company’s stock, valued at approximately $5,270,162.48. The trade was a 16.20% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 154,168 shares of company stock valued at $10,491,896. Insiders own 0.59% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in DOCU. Choreo LLC raised its stake in shares of Docusign by 1.8% in the third quarter. Choreo LLC now owns 7,430 shares of the company’s stock worth $499,000 after buying an additional 129 shares during the period. Private Advisor Group LLC lifted its stake in shares of Docusign by 0.9% in the 3rd quarter. Private Advisor Group LLC now owns 14,885 shares of the company’s stock valued at $1,000,000 after purchasing an additional 135 shares during the last quarter. Bessemer Group Inc. boosted its stake in Docusign by 15.6% during the third quarter. Bessemer Group Inc. now owns 1,262 shares of the company’s stock worth $85,000 after buying an additional 170 shares during the period. Covestor Ltd raised its position in Docusign by 14.1% in the 3rd quarter. Covestor Ltd now owns 1,693 shares of the company’s stock worth $113,000 after purchasing an additional 209 shares during the period. Finally, Pzena Investment Management LLC lifted its stake in shares of Docusign by 4.7% during the 3rd quarter. Pzena Investment Management LLC now owns 4,720 shares of the company’s stock worth $317,000 after acquiring an additional 210 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About Docusign

(Get Free Report)

DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.

Featured Stories

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.